Navigation Links
Janssen and Johnson & Johnson to Provide Webcast Presentation on the Janssen Oncology Hematologic Malignancy Portfolio
Date:1/15/2016

NEW BRUNSWICK, N.J., Jan. 15, 2016 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) and Johnson & Johnson (NYSE: JNJ) will provide a pre-recorded webcast focused on data from the Janssen Oncology hematologic malignancy portfolio for investors and other interested parties on Friday, January 15.

The pre-recorded webcast features Peter F. Lebowitz, MD, PhD, Global Therapeutic Area Head of Oncology for Janssen R&D, recapping key data presentations on DARZALEX™ (daratumumab) and IMBRUVICA® (ibrutinib) that were featured at the 2015 American Society of Hematology (ASH) Annual meeting. Dr. Lebowitz will also describe the development plans for these and other compounds in the Janssen Oncology hematologic malignancy portfolio.

The webcast/podcast can be accessed by visiting the Johnson & Johnson website at www.investor.jnj.com and clicking on "Webcasts/Presentations." The webcast duration is approximately 18 minutes and will be available through the end of February.


'/>"/>
SOURCE Johnson & Johnson
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. WuXi AppTec Congratulates Chia Tai Tianqing Pharmaceutical Group and Janssen for Licensing Agreement
2. ViiV Healthcare to Progress Collaboration with Janssen to Develop the First Long-acting, Two Drug Injectable Regimen for Treatment of HIV-1 Infection
3. Janssen Announces Collaboration with Bavarian Nordic to Develop Vaccine for Chronic Human Papillomavirus (HPV) Infections
4. Janssen to Showcase Growing Portfolio with More Than 40 Data Presentations at the 2015 American Society of Hematology (ASH) Annual Meeting
5. Head Janssen Neuroscientist Appointed to Scientific Advisory Board of Global Dementia Discovery Fund
6. Leitender Neurowissenschaftler bei Janssen in den Wissenschaftlichen Beirat des globalen Dementia Discovery Fund bestellt
7. Janssen Tackles Mental Health Stigma in New Healthy Minds Videos
8. U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma
9. New Study by TSRI and Janssen Makes Major Advance Toward More Effective, Long-Lasting Flu Vaccine
10. Black Celebrities Come Out to Honor 2015 Heroes in the Struggle Honoring Jussie Smollett, Gregorio Millett, Vanessa Mills, and Janssen Therapeutics
11. Janssen Initiates Rolling Submission of Biologic License Application (BLA) for daratumumab with U.S. FDA for the Treatment of Multiple Myeloma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/5/2020)... ... April 05, 2020 , ... INTRODUCTION , ... aetiology and pathology of COVID-19[1], we are committed to the non-profit dissemination of ... , The SARS-CoV-2-mediated post-entry suppression of ACE2 mRNA expression in host cells is ...
(Date:4/2/2020)... ... April 02, 2020 , ... On April ... be initiating the 2nd annual Medical Hero Appreci-a-thon to bring the global clinical ... and healthcare professionals, researchers and study volunteers. CISCRP invites the public to ...
(Date:4/1/2020)... ... April 01, 2020 , ... In response ... shields. As large manufacturers nation-wide scramble to retool their machinery to build N95 ... in extreme cases, using hand-sewn masks to protect employees from contracting infectious diseases. ...
Breaking Medicine Technology:
(Date:4/2/2020)... (PRWEB) , ... April 02, 2020 , ... ... Support Software, An FDAnews Webinar, Tuesday April 7, 2020, 1:30-3:00 p.m. EDT, ... include FDA regulation of AI used to guide clinical management of the Coronavirus.* ...
(Date:4/2/2020)... ... April 02, 2020 , ... Since the onset of the ... standards and practices. GoParrot ( https://www.goparrot.ai/ ) founder Yaniv Nissim has stepped up ... virus control and food safety, has created new standards for delivering food during this ...
(Date:4/1/2020)... ... ... Medical Device Change Management, An FDAnews Webinar , Thursday, April 16, 2020, ... method should one be using for a medical device? , The answer is, ... it due to post-market design change, production process changes, QMS process changes, corrective action ...
(Date:4/1/2020)... ... April 01, 2020 , ... Velocidy Bio ’s Dutch biotech partner, Molecular ... that decreases the testing time for SARS-CoV-2 to eight minutes, compared to current systems ... a shoebox could perform a hundred and eighty (180) amplification runs a day, an ...
(Date:3/30/2020)... ... March 30, 2020 , ... Achieve Medical Center now ... to provide comprehensive and compassionate mental health and wellness services in the midst ... platform for telemedicine services including initial consultations, evaluations, and follow-up care. It also ...
Breaking Medicine News(10 mins):